See What's Next in Clinical Trial Feasibility
Join TriNetX at SCOPE Europe 2026
Booth #68 | Barcelona, Spain | October 13-14, 2026
Discover how deeper, connected real-world data, including genomics, clinical notes, and AI-powered insights, can help clinical teams improve feasibility assessments, identify the right sites faster, and accelerate study success.
Meet with our experts at Booth #68
Featured Speaking Session
Feasibility Without Guesswork: How Deeper Data (and Genomics) Improves Feasibility and Site Identification with Confidence
Date: Tuesday, October 13, 2026
Time: 9:50 AM (25 Minutes)
Track: C4: Clinical Data Strategy and AI Innovation
Presenter: Samantha Eells
Clinical trial feasibility is often slowed by fragmented data and assumptions that can lead to protocol amendments, startup delays, and underperforming sites. In this session, learn how enriched real-world data, including genomics and clinical notes, can help teams evaluate protocol criteria more effectively, identify high-performing sites with eligible patient populations, and make faster, evidence-based decisions.
Key Takeaways
- Improve protocol feasibility with deeper patient-level insights
- Identify sites with greater confidence
- Leverage genomics and unstructured data to uncover hidden opportunities
- Reduce trial startup risk and accelerate execution
Continuing the Conversation
Webinar Coming Soon
If you can’t join us in Barcelona, or want a deeper dive after the conference, register for our upcoming webinar expanding on the concepts shared during Samantha’s presentation.
What We’ll Cover
-
Real-world examples of data-driven feasibility
-
Using genomics in protocol planning and site identification
-
How AI helps transform feasibility workflows
-
Practical approaches for improving trial execution
Join us in Barcelona
"*" indicates required fields